Low dose maintenance medication for schizophrenia.
作者信息
Manchanda R, Hirsch S R
出版信息
Br Med J (Clin Res Ed). 1986 Aug 30;293(6546):515-6. doi: 10.1136/bmj.293.6546.515.
Abstract
摘要
相似文献
1
Low dose maintenance medication for schizophrenia.用于精神分裂症的低剂量维持药物。
Br Med J (Clin Res Ed). 1986 Aug 30;293(6546):515-6. doi: 10.1136/bmj.293.6546.515.
2
Strategies for enhancing drug therapy of schizophrenia.
Am J Psychother. 1983 Oct;37(4):521-32. doi: 10.1176/appi.psychotherapy.1983.37.4.521.
3
Schizophrenia (maintenance treatment).精神分裂症（维持治疗）。
Am Fam Physician. 2010 Aug 15;82(4):338-9.
4
The natural course of schizophrenia and effective maintenance drug treatment.精神分裂症的自然病程与有效的维持性药物治疗
J Clin Psychopharmacol. 1986 Feb;6(1 Suppl):2S-10S.
5
Medication-free minors with schizophrenia.未服用药物的患精神分裂症未成年人。
Am J Psychiatry. 2001 Feb;158(2):324. doi: 10.1176/appi.ajp.158.2.324.
6
Long-acting injectable antipsychotics in the treatment of schizophrenia: their role in relapse prevention.长效注射用抗精神病药物治疗精神分裂症：预防复发的作用。
Expert Opin Pharmacother. 2010 Oct;11(14):2301-17. doi: 10.1517/14656566.2010.499125.
7
Maintenance therapy and the natural course of schizophrenia.精神分裂症的维持治疗与自然病程
J Clin Psychiatry. 1985 Nov;46(11 Pt 2):18-21.
8
Risks of intermittent antipsychotic treatment in schizophrenia.精神分裂症间歇性抗精神病药物治疗的风险
J Clin Psychiatry. 2011 Jan;72(1):114; author reply 114-5. doi: 10.4088/JCP.10lr06452ye.
9
Continuous versus intermittent neuroleptic therapy in schizophrenia.
Drug Saf. 1993 May;8(5):331-9. doi: 10.2165/00002018-199308050-00001.
10
Information processing and maintenance dose requirements in schizophrenia.精神分裂症中的信息处理与维持剂量需求
Psychopharmacol Bull. 1988;24(2):247-50.
引用本文的文献
1
Long-term depot antipsychotics. A risk-benefit assessment.长效抗精神病药物。风险效益评估。
Drug Saf. 1994 Jun;10(6):464-79. doi: 10.2165/00002018-199410060-00005.
2
Psychotropic drugs.精神药物
Br Med J (Clin Res Ed). 1987 Jan 17;294(6565):167-9. doi: 10.1136/bmj.294.6565.167.
本文引用的文献
1
Costs and benefits of two doses of fluphenazine.两剂氟奋乃静的成本与效益
Arch Gen Psychiatry. 1984 Nov;41(11):1025-9. doi: 10.1001/archpsyc.1983.01790220015002.
2
Low-dose neuroleptic treatment of outpatient schizophrenics. I. Preliminary results for relapse rates.
Arch Gen Psychiatry. 1983 Aug;40(8):893-6. doi: 10.1001/archpsyc.1983.01790070083010.
3
Depot neuroleptics: the relevance of psychosocial factors--a United States perspective.长效抗精神病药物：社会心理因素的相关性——美国视角
J Clin Psychiatry. 1984 May;45(5 Pt 2):36-42.
4
The discontinuance of maintenance neuroleptic therapy in chronic schizophrenic patients: drug and social consequences.
Acta Psychiatr Scand. 1983 May;67(5):339-52. doi: 10.1111/j.1600-0447.1983.tb00351.x.
5
What is the best maintenance dose of neuroleptics in schizophrenia?治疗精神分裂症时，抗精神病药物的最佳维持剂量是多少？
Psychiatry Res. 1980 Oct;3(2):115-22. doi: 10.1016/0165-1781(80)90028-1.
6
Outpatient maintenance of chronic schizophrenic patients with long-acting fluphenazine: double-blind placebo trial. Report to the Medical Research Council Committee on Clinical Trials in Psychiatry.长效氟奋乃静对慢性精神分裂症患者的门诊维持治疗：双盲安慰剂试验。提交给医学研究委员会精神病学临床试验委员会的报告。
Br Med J. 1973 Mar 17;1(5854):633-7. doi: 10.1136/bmj.1.5854.633.
7
Selection of neuroleptic dosage.抗精神病药物剂量的选择。
Arch Gen Psychiatry. 1985 Jun;42(6):636-7. doi: 10.1001/archpsyc.1985.01790290118019.
8
Antipsychotic medication: clinical guidelines for maintenance therapy.抗精神病药物：维持治疗临床指南
J Clin Psychiatry. 1985 May;46(5 Pt 2):6-15.
9
Further observations on the duration of depot neuroleptic maintenance therapy in schizophrenia.关于精神分裂症长效抗精神病药物维持治疗疗程的进一步观察
Br J Psychiatry. 1979 Dec;135:524-30. doi: 10.1192/bjp.135.6.524.
10
Temporal effects of drug and placebo in delaying relapse in schizophrenic outpatients.药物和安慰剂对精神分裂症门诊患者延迟复发的时间效应。
Arch Gen Psychiatry. 1977 Mar;34(3):297-301. doi: 10.1001/archpsyc.1977.01770150055005.
Zotero 插件